Arcutis Biotherapeutics (ARQT)
Quick facts
| Ticker | ARQT (NASDAQ) |
|---|
Marketed products
- Daliresp · Immunology
Daliresp works by blocking an enzyme called phosphodiesterase 4, which helps reduce inflammation in the body.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: